Inventory, Net of NAVIDEA BIOPHARMACEUTICALS, INC. from 31 Dec 2010 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly Inventory, Net in USD history and change rate from 31 Dec 2010 to 30 Sep 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Inventory, Net for the quarter ending 30 Sep 2023 was $460,746, a 138% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $460,746 +$266,940 +138% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $460,746 +$145,076 +46% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $460,636 +$137,644 +43% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $427,344 +$276,189 +183% 31 Dec 2022 10-Q 14 Nov 2023 2023 Q3
Q3 2022 $193,806 +$14,871 +8.3% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $315,670 +$136,840 +77% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $322,992 +$156,750 +94% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $151,155 -$18,643 -11% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $178,935 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $178,830 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $166,242 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $169,798 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q1 2017 $748,000 -$150,936 -17% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $96,208 -$556,698 -85% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 $804,882 -$72,301 -8.2% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $769,820 -$425,289 -36% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 $898,936 +$327,331 +57% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $652,906 -$279,479 -30% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 $877,183 -$243,035 -22% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $1,195,109 -$710,654 -37% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $571,605 -$1,542,310 -73% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 $932,385 -$1,300,051 -58% 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q3 2014 $1,120,218 -$922,566 -45% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 $1,905,763 +$576,011 +43% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 $2,113,915 +$1,246,648 +144% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 $2,232,436 +$1,934,936 +650% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $2,042,784 +$1,401,784 +219% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $1,329,752 +$411,252 +45% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 $867,267 -$51,233 -5.6% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $297,500 -$524,049 -64% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q3 2012 $641,000 -$203,203 -24% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 $918,500 -$723,595 -44% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $918,500 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $821,549 +$189,549 +30% 31 Dec 2011 10-K/A 21 Mar 2013 2012 FY
Q3 2011 $844,203 30 Sep 2011 10-Q 09 Nov 2011 2011 Q3
Q2 2011 $1,642,095 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q4 2010 $632,000 31 Dec 2010 10-K 07 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.